2m 2m 2m 2m 2m 2m 2m
Integra Life Hld (IART)
NASDAQ
$17.69+$0.09 (+0.51%)
Price as of Jun 23, 2026 7:09 PM EDT- $1.4BMarket Cap
- 51.46%1-Year Change
- Medical DevicesIndustry
Integra Life Hld (IART)
$17.69+$0.09 (+0.51%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.6B +1.53% | 1.6B +4.47% | 1.5B -1.03% | 1.6B +0.99% | |
Cost of Revenue | 803.6M +10.32% | 728.5M +10.90% | 656.8M +11.83% | 587.4M -1.75% | |
Gross Profit | 831.6M -5.72% | 882.1M -0.30% | 884.7M -8.82% | 970.3M +2.72% | |
Sales and Marketing Expense | 699.7M -2.41% | 717.0M +9.19% | 656.6M +6.54% | 616.3M -3.31% | |
Research and Development Expense | -99.0M -14.22% | -115.4M +10.73% | -104.2M +2.96% | -101.2M +8.75% | |
Depreciation and Amortization Expense | 151.8M +7.76% | 140.9M +14.07% | 123.5M +4.41% | 118.3M -1.28% | |
Total Operating Expenses | 2.1B +34.54% | 1.6B +10.63% | 1.4B +8.44% | 1.3B -1.97% | |
Operating Profit | -493.4M -1,836.55% | 28.4M -74.53% | 111.5M -53.32% | 238.9M +21.14% | |
Interest Income | 18.5M -7.81% | 20.0M +16.50% | 17.2M +44.35% | 11.9M +76.89% | |
Interest Expense | N/A N/A | N/A N/A | -51.4M +3.60% | -49.6M -1.59% | |
Interest Income and Expense and Net | 18.5M -7.81% | 20.0M +158.64% | -34.2M -9.29% | -37.7M -13.70% | |
Total Nonoperating Income and Expense | -2.4M -159.61% | 3.9M +6.08% | 3.7M -69.03% | 12.0M -37.81% | |
Income before Taxes | -563.5M +2,989.88% | -18.2M -122.50% | 81.1M -62.10% | 213.9M -0.36% | |
Income Taxes | -47.0M +316.43% | -11.3M -184.73% | 13.3M -60.03% | 33.3M -26.88% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -516.5M +7,337.70% | -6.9M -110.25% | 67.7M -62.48% | 180.6M +6.79% | |
Net Income from Continuing Operations Applicable to Common | -563.5M +2,989.88% | -18.2M -122.50% | 81.1M -62.10% | 213.9M -0.36% | |
Basic EPS and Net Income | -6.74 +7,388.89% | -0.09 -110.59% | 0.85 -61.01% | 2.18 +9.00% | |
Diluted EPS and Net Income | -6.74 +7,388.89% | -0.09 -110.71% | 0.84 -61.11% | 2.16 +9.09% | |
Basic Weighted Average Shares | 76.7M -0.44% | 77.0M -3.84% | 80.1M -3.50% | 83.0M -2.01% | |
Diluted Weighted Average Shares | 76.7M -0.44% | 77.0M -4.14% | 80.3M -3.81% | 83.5M -2.30% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 235.0M -4.60% | 246.4M -10.86% | 276.4M -39.47% | 456.7M -11.06% | |
Short-Term Investments | 28.7M +5.52% | 27.2M -16.83% | 32.7M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 263.7M -3.59% | 273.6M -11.49% | 309.1M -32.31% | 456.7M -11.06% | |
Total Current Assets | 1.2B +7.20% | 1.1B +2.23% | 1.1B -8.91% | 1.2B +0.67% | |
Accumulated Depreciation | 444.0M +11.85% | 396.9M +8.02% | 367.4M +11.44% | 329.7M +4.72% | |
Property and Plant and Equipment and Net | 444.3M +9.52% | 405.7M +19.26% | 340.2M +9.28% | 311.3M -0.13% | |
Total Long-Term Assets | 37.9M -43.05% | 66.5M +14.30% | 58.2M +1.76% | 57.2M +247.87% | |
Total Assets | 3.6B -10.78% | 4.0B +6.75% | 3.8B -2.77% | 3.9B +2.84% | |
Income Taxes Payable | 9.3M -84.69% | 60.8M +72.25% | 35.3M -44.24% | 63.3M +38.33% | |
Total Short-Term Debt | 38.8M -93.62% | 607.1M +4,077.80% | 14.5M -61.89% | 38.1M -15.28% | |
Total Current Liabilities | 456.0M -50.55% | 922.1M +200.39% | 307.0M -4.34% | 320.9M -5.62% | |
Total Long-Term Debt | 1.7B +58.98% | 1.1B -22.06% | 1.4B +7.33% | 1.3B -6.35% | |
Total Long-Term Liabilities | 204.3M +39.69% | 146.2M -26.86% | 199.9M +44.36% | 138.5M +15.17% | |
Total Liabilities | 2.6B +2.66% | 2.5B +13.58% | 2.2B +5.21% | 2.1B -0.58% | |
Retained Earnings | 423.4M -54.95% | 939.9M -0.73% | 946.9M +7.71% | 879.1M +25.85% | |
Total Stockholders Equity | 1.0B -32.47% | 1.5B -2.68% | 1.6B -12.00% | 1.8B +7.10% | |
Total Shares Outstanding | 92.3M +0.74% | 91.6M +0.76% | 90.9M +0.49% | 90.5M +0.98% | |
Cash Flow | |||||
Cash from Operating Activities | 50.4M -61.06% | 129.4M -7.55% | 140.0M -47.08% | 264.5M -15.35% | |
Capital Expenditures | 81.4M -22.01% | 104.4M +56.16% | 66.9M +57.91% | 42.3M -11.83% | |
Cash from Investing Activities | -108.1M -72.35% | -390.8M +314.97% | -94.2M +60.77% | -58.6M -63.71% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 28.3M -88.09% | 237.9M +203.45% | -229.9M -8.74% | -252.0M +156.50% | |
Financials Ratio | |||||
Gross Margin | 50.86% -7.14% | 54.77% -4.57% | 57.39% -7.87% | 62.29% +1.71% | |
Operating Margin | -30.17% -1,810.28% | 1.76% -75.62% | 7.23% -52.83% | 15.34% +19.95% | |
Return on Assets | -13.52% +7,513.34% | -0.18% -110.06% | 1.77% -62.48% | 4.71% +2.96% | |
Return on Equity | -39.90% +8,901.02% | -0.44% -111.10% | 3.99% -61.41% | 10.35% -2.07% | |
Revenue Growth | 1.53% -65.69% | 4.47% +532.97% | -1.03% -204.71% | 0.99% -92.07% | |
Current Ratio | 2.54 +116.79% | 1.17 -65.97% | 3.45 -4.77% | 3.62 +6.67% | |
Cash Ratio | 0.52 +92.93% | 0.27 -70.32% | 0.90 -36.73% | 1.42 -5.76% | |
Debt-to-Equity Ratio | 1.69 +54.50% | 1.10 +23.50% | 0.89 +19.72% | 0.74 -12.81% | |
Debt-to-Assets Ratio | 0.49 +16.94% | 0.42 +12.58% | 0.37 +8.37% | 0.34 -9.21% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow